Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 1
Merck Claims Evidence Shows Plaintiff Seeking Damages in Excess of Jurisdictional Limit
Ohio Supreme Court Refuses to Review Decision Awarding Merck Summary Judgment
Plaintiffs Failed to State Viable Cause of Action against Doctor, Research Clinic
Plaintiff's Lack of Representation Leads to Dismissal with Prejudice
Suit Claims Injuries Caused by Remicade Required Amputation of Both Feet
Arthritis Drugs - Issue: 2
Magistrate Says Complaint Fails to Provide Facts Supporting Claims against Physicians
Arthritis Drugs - Issue: 4
Vioxx Maker Claims Lack of Evidence Warrants Summary Judgment
Arthritis Drugs - Issue: 5
A Discussion With David F. Miceli About Vioxx Litigation
